Invesco Biotechnology & Genome ETF (PBE)
83.81
-0.35
(-0.42%)
USD |
NYSEARCA |
Dec 26, 16:00
83.81
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.58% | 0.11% | 264.84M | 6748.43 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.36% | 94.00% | -39.48M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the Dynamic Biotech & Genome Intellidex. The Fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the Underlying Intellidex in proportion to their weightings in the index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Invesco |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 26, 2025.
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.02% |
| Stock | 99.94% |
| Bond | 0.01% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.03% |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the Dynamic Biotech & Genome Intellidex. The Fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the Underlying Intellidex in proportion to their weightings in the index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Invesco |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |